Reuters. Elon Musk, Neuralink's billionaire founder, said the first human received an implant from the brain-chip startup on Sunday (January 28) and is recovering well, in a post on social media platform X on Monday (January 29).
The U.S. Food and Drug Administration had given the company clearance last year to conduct its first trial to test its implant on humans.
"The first Neuralink product is called Telepathy," Musk added.
The study will assess the functionality of the interface which enables people with quadriplegia, or paralysis of all four limbs, to control devices with their thoughts, according to the company's website.
Neuralink did not immediately respond to a Reuters request for further details.
